Compounds > thiazolidines
Page last updated: 2024-08-21

thiazolidines and Cell Transformation, Neoplastic

thiazolidines has been researched along with Cell Transformation, Neoplastic in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19907 (87.50)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Choi, KY; Han, G; Lee, SH; Ryu, WJ1
Brugarolas, A; Gosalvez, M1
McCarty, MF1
Coppey, J; Magdelenat, H; Rigaud, O1
Blanco, MF; de Paz, E; Gosálvez, M1
Banks, AR; Hessek, E; Jones, T; Parks, RC1
Gosalvez, M1
Cui, XX1

Reviews

1 review(s) available for thiazolidines and Cell Transformation, Neoplastic

ArticleYear
Cytostatic and reverse-transforming therapies of cancer - a brief review and future prospects.
    Medical hypotheses, 1982, Volume: 8, Issue:6

    Topics: Animals; Antineoplastic Agents; Benzaldehydes; Cell Transformation, Neoplastic; Cyclic AMP; Growth Inhibitors; Humans; Interferons; Neoplasms; Protease Inhibitors; Solvents; Thiazoles; Thiazolidines; Vitamin A

1982

Other Studies

7 other study(ies) available for thiazolidines and Cell Transformation, Neoplastic

ArticleYear
Suppression of Wnt/β-catenin and RAS/ERK pathways provides a therapeutic strategy for gemcitabine-resistant pancreatic cancer.
    Biochemical and biophysical research communications, 2021, 04-16, Volume: 549

    Topics: beta Catenin; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Deoxycytidine; Gemcitabine; Humans; MAP Kinase Signaling System; Neoplasm Metastasis; Pancreatic Neoplasms; Proteolysis; Proto-Oncogene Proteins p21(ras); ras Proteins; Thiazolidines; Wnt Signaling Pathway

2021
Treatment of cancer by an inducer of reverse transformation.
    Lancet (London, England), 1980, Jan-12, Volume: 1, Issue:8159

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carboxylic Acids; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Neoplasms; Thiazoles; Thiazolidines

1980
Lack of reverse transformation after treatment of A 549 human alveolar carcinoma cells with thioproline.
    Cancer letters, 1983, Volume: 20, Issue:1

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Cell Division; Cell Line; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Phenotype; Thiazoles; Thiazolidines

1983
[Transrecters. A new group of inducers of reverse transformation with possible use in the treatment of human cancer].
    Revista espanola de oncologia, 1982, Volume: 29, Issue:4

    Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; HeLa Cells; Humans; Neoplasms; Thiazoles; Thiazolidines

1982
Thioproline: an inhibitor of chemical carcinogenesis.
    Neoplasma, 1982, Volume: 29, Issue:5

    Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Female; Methylcholanthrene; Mice; Mice, Inbred DBA; Neoplasms, Experimental; Thiazoles; Thiazolidines

1982
On the irreproducibility of thioproline.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1982, Volume: 36, Issue:8-9

    Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Drug Synergism; HeLa Cells; Humans; Thiazoles; Thiazolidines

1982
[Malignant transformation of NIH 3T3 cells by urine NTCA in normal population of Lin-xian County].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1989, Volume: 11, Issue:2

    Topics: Animals; Cell Transformation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Nitroso Compounds; Rats; Thiazoles; Thiazolidines

1989